J. Cosmet. Sci., 60, 15–24 (January/February 2009)SynopsisHydrogenated polyisobutene (HP) is used in topically applied cosmetic/personal care formulations as an emollient that leaves a pleasing skin feel when applied, and rubbed in after application. This effect, although distinguishable to the user, is difficult to define and quantify. Recognizing that some of the physical properties of HP such as film formation and wear resistance may contribute, in certain mechanisms, to skin moisturization, we designed a short‐term pilot study to follow changes in skin moisturization. HP’s incorporation into an o/w emulsion at 8% yielded increased viscosity and reduced emulsion droplet size as compared to the emollient ester CCT (capric/caprylic triglyceride) or a control formulation. Quantitative data indicate that application of the o/w emulsion formulation containing either HP or CCT significantly elevated skin moisture content and thus reduced transepidermal water loss (TEWL) by a maximal ∼33% against the control formulation within 3 h and maintained this up to 6 h. Visual observation of skin treated with the HP‐containing formulation showed fine texture and clear contrast as compared to the control or the CCT formulation, confirming this effect. As a result of increased hydration, skin conductivity, as measured in terms of corneometer values, was also elevated significantly by about tenfold as early as 20 min after HP or CCT application and was maintained throughout the test period. Throughout the test period the HP formulation was 5–10% more effective than the CCT formulation both in reduction of TEWL as well as in increased skin conductivity. Thus, compared to the emollient ester (CCT), HP showed a unique capability for long‐lasting effect in retaining moisture and improving skin texture.

Journal of cosmetic science4区 · 医学

Structure/property comparisons of chemistries based on renewable 1,3-propanediol and petroleum-derived alkylene oxides.

4区 · 医学

Article

作者: Mayer, Pat ; Anthonavage, Michael ; Riemer, Jed ; Lind, Eric ; Chase, John ; Russo, Tom ; Dres-Hajeski, Caren

Structure/property comparisons were made of chemistries based on renewable 1,3-propanediol (PDO)- versus petroleum-based alkylene oxides as well as comparisons of the respective polyethers, emulsifiers, and cosmetic formulations based on these feedstocks. Green Chemistry Principles were applied in the manufacture of polyethylene glycol (PEG)-free renewable PDO-based oligomers and PDO-based fatty acid ester emulsifiers. Sustainable cosmetic products formulated with renewable PDO-based emulsifiers gave equivalent performance in sensory and moisturization evaluations compared to those formulated with the petroleum-derived PEG-based emulsifiers.

Cosmetics & Toiletries

Oleic acid-induced skin penetration effects of a lamellar delivery system

作者: Batheja, P. ; Michniak, B. ; Dayan, N.

The structure and thermodn. state of the skin's lipid barrier are correlated with the skin's penetration profile in this in vitro study using a delivery system composed of phospholipids, oleic acid, oil and water.Elevated percentages of oleic acid in the system affect the lipid barrier's structure and thermodn. properties.

项与 Vantage Specialty Ingredients, Inc. 相关的新闻（医药）

2022-06-24

·PRNewswire

Patients With Recalled Exactech Devices May Be Encouraged to Settle Before Contacting Lawyer

The Law Offices of James Scott Farrin encourages patients to speak to an attorney before agreeing to anything from Exactech or its settlement company. DURHAM, N.C., June 24, 2022 /PRNewswire/ -- The Law Offices of James Scott Farrin is encouraging those affected by the recall of certain Exactech replacement joints to consider their legal options. Patients may have already been contacted by Exactech or its representatives but should be cautious. Exactech has hired a settlement company to help, but patients should know that the company does not represent patients or their best interests. It is highly recommended to speak to a defective products lawyer to determine your options. Exactech Recall: Why It Happened and Consequences for Patients Exactech recently recalled nearly 150,000 of its OPTETRAK®, OPTETRAK Logic®, TRULIANT®, and VANTAGE® implants for knees and ankles due to a packaging defect that may have allowed the delicate polyethylene liners to oxidize, potentially leading to premature wear, degradation, and failure. The company's recall is considered a Class II recall by the FDA, meaning the devices' failures may cause "temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." However, the consequences for patients can be quite serious. Failing devices can cause many medical problems, and revision surgery could be risky, involve serious expense, and require lengthy recovery and rehabilitation times. Patients should be aware of the real possible costs of the recall and consequences to them before agreeing to anything. Multiple Exactech Lawsuits May Be on the Horizon – Act Now The Law Offices of James Scott Farrin is prepared to assist patients affected by this recall. If you or anyone you know has a recalled Exactech device, you are encouraged to seek counsel from an experienced product liability attorney. Contact the firm for a free case evaluation at farrin.com/contact or call 1-866-900-7078. The Law Offices of James Scott Farrin consults with a national network of attorneys on defective products cases in an attempt to provide the best representation for clients. Depending on the details of the case, the firm will likely refer the matter to another law firm with which they associate. They will only do this if they believe it is in the client's interests and if the client agrees. About the Law Offices of James Scott Farrin The Law Offices of James Scott Farrin is one of the largest personal injury firms in North Carolina, and has helped more than 55,000 injured people since 1997. Many of the firm's more than 60 accomplished attorneys have won awards and are recognized professionals in their fields. The firm is headquartered in Durham, North Carolina. Contact Information: David Chamberlin 280 S. Mangum Street, Suite 400 Durham, NC 27701 866-900-7078 Offices in Durham (main), Raleigh, Charlotte, Greensboro, NC and Greenville, SC. Attorney J. Gabe Talton: 280 South Mangum St., Suite 400, Durham, NC. SOURCE Law Offices of James Scott Farrin

2022-06-13

·PRNewswire

Dr. Thomas Stricker Joins OneOncology as Medical Director for Precision Medicine

NASHVILLE. Tenn., June 13, 2022 /PRNewswire/ -- OneOncology, the national platform for independent oncology practices, today appointed Thomas Stricker, MD as Medical Director for Precision Medicine. Dr. Stricker will work with partner practices to create workflows that reduce physicians' burden of genomic test ordering and interpretation, so they have more time to spend with their patients. Dr. Stricker reports to Chief Medical Officer, Davey Daniel, MD. Stricker says he sees three pillars of assistance for testing that he and his team can provide to physician partners: Tom Strickland, MD, joins OneOncology as Medical Director for Precision Medicine. Stricker will work with practices to to reduce physicians' burden of genomic test ordering and interpretation. Tweet this 1) At order, to make sure the right tests are ordered. 2) At initial result, to make sure that the appropriate therapy is given based on the current data. 3) At recurrence or progression, to identify additional options whether they or standard of care or a clinical trial option. "The complexity of pathology standards in oncology necessitates a change in the way that results are delivered, such as comprehensive reports that summarize the key data from multiple tests," Dr. Stricker said. "I am excited to help build systems that can empower our physicians to maximize the value of testing during each stage." Dr. Stricker was most recently an Assistant Professor in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University where he founded the Somatic Clinical Sign-out Team and the Clinical Genomics Lab, which generates whole exome and other germline sequencing panels. Dr. Stricker also served as associate director of VANTAGE, the research sequencing core for Vanderbilt. At Vanderbilt, Dr. Stricker also served on molecular tumor boards and was on the team that founded GENIE, an American Association for Cancer Research initiative for the sharing of genomic cancer sequencing data across institutions. Dr. Stricker has extensive experience in generating and analyzing Next Generation Sequencing data, and in generating and signing out clinical genomic reports. "Dr. Stricker has extensive experience in genomic sequencing, research and developing data integrations across cancer institutions," said Davey Daniel, MD, OneOncology's Chief Medical Officer. "His knowledge, experience and vision are a perfect fit to support our physicians' abilities to use genomic testing to match the right treatment or trial at the right time – all in oncology practices that are conveniently located close to where patients live." Dr. Stricker earned his MD and PhD from Washington University in St. Louis. Following a residency in Anatomical Pathology and a fellowship in Bone and Soft Tissue at The University of Chicago, he joined Dr. Kevin White's lab in the Institute for Genomics and Systems Biology as a post-doctoral fellow. While there, he developed expertise in generating and analyzing data from the then-new next generation sequencing technologies. About OneOncology OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer. Our goal is to enable community oncology practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. OneOncology supports our platform of community oncology practices through group purchasing, operational optimization, practice growth, and clinical innovation. Our 700 cancer care providers care for 280,000 patients at 181 sites of care nationwide. To learn more, visit oneoncology.com or LinkedIn. SOURCE OneOncology

AACR会议

2021-02-12

·GlobeNewswire

Global Isostearic Acid Industry

New York, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Isostearic Acid Industry" - 8 Million by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Personal Care, one of the segments analyzed in the report, is projected to record a 6.3% CAGR and reach US$269.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chemical Esters segment is readjusted to a revised 5.5% CAGR for the next 7-year period. The U.S. Market is Estimated at $161.1 Million, While China is Forecast to Grow at 8.9% CAGR The Isostearic Acid market in the U.S. is estimated at US$161.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$187.1 Million by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR. Lubricants Segment to Record 6.1% CAGR In the global Lubricants segment, USA, Canada, Japan, China and Europe will drive the 5.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$89.5 Million in the year 2020 will reach a projected size of US$130.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$119 Million by the year 2027, while Latin America will expand at a 7.3% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others, BOC Sciences Croda International PLC Foreverest Resources Ltd. Jarchem Industries, Inc. Kraton Corporation MilliporeSigma Oleo Solutions Ltd. Santa Cruz Biotechnology, Inc. SysKem Chemie GmbH Vantage Specialty Ingredients, Inc. Read the full report: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Isostearic Acid Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: Isostearic Acid Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 2: Isostearic Acid Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 Table 3: Isostearic Acid Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Personal Care (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027 Table 5: Personal Care (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019 Table 6: Personal Care (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Chemical Esters (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027 Table 8: Chemical Esters (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019 Table 9: Chemical Esters (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 Table 10: Lubricants (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 11: Lubricants (Application) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019 Table 12: Lubricants (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 Table 13: Other Applications (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027 Table 14: Other Applications (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019 Table 15: Other Applications (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Isostearic Acid Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 16: United States Isostearic Acid Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 Table 17: Isostearic Acid Historic Demand Patterns in the United States by Application in US$ Thousand for 2012-2019 Table 18: Isostearic Acid Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 CANADA Table 19: Canadian Isostearic Acid Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 Table 20: Isostearic Acid Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019 Table 21: Canadian Isostearic Acid Market Share Analysis by Application: 2012 VS 2020 VS 2027 JAPAN Table 22: Japanese Demand Estimates and Forecasts for Isostearic Acid in US$ Thousand by Application: 2020 to 2027 Table 23: Japanese Isostearic Acid Market in US$ Thousand by Application: 2012-2019 Table 24: Isostearic Acid Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 CHINA Table 25: Chinese Demand for Isostearic Acid in US$ Thousand by Application: 2020 to 2027 Table 26: Isostearic Acid Market Review in China in US$ Thousand by Application: 2012-2019 Table 27: Chinese Isostearic Acid Market Share Breakdown by Application: 2012 VS 2020 VS 2027 EUROPE Market Facts & Figures European Isostearic Acid Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 28: European Isostearic Acid Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 Table 29: Isostearic Acid Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 Table 30: European Isostearic Acid Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 31: European Isostearic Acid Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 Table 32: Isostearic Acid Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019 Table 33: European Isostearic Acid Market Share Analysis by Application: 2012 VS 2020 VS 2027 FRANCE Table 34: Isostearic Acid Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027 Table 35: French Isostearic Acid Historic Market Review in US$ Thousand by Application: 2012-2019 Table 36: French Isostearic Acid Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 GERMANY Table 37: Isostearic Acid Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 Table 38: German Isostearic Acid Market in Retrospect in US$ Thousand by Application: 2012-2019 Table 39: Isostearic Acid Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 ITALY Table 40: Italian Demand for Isostearic Acid in US$ Thousand by Application: 2020 to 2027 Table 41: Isostearic Acid Market Review in Italy in US$ Thousand by Application: 2012-2019 Table 42: Italian Isostearic Acid Market Share Breakdown by Application: 2012 VS 2020 VS 2027 UNITED KINGDOM Table 43: United Kingdom Demand Estimates and Forecasts for Isostearic Acid in US$ Thousand by Application: 2020 to 2027 Table 44: United Kingdom Isostearic Acid Market in US$ Thousand by Application: 2012-2019 Table 45: Isostearic Acid Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 SPAIN Table 46: Spanish Isostearic Acid Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 Table 47: Isostearic Acid Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019 Table 48: Spanish Isostearic Acid Market Share Analysis by Application: 2012 VS 2020 VS 2027 RUSSIA Table 49: Russian Isostearic Acid Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 Table 50: Isostearic Acid Historic Demand Patterns in Russia by Application in US$ Thousand for 2012-2019 Table 51: Isostearic Acid Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027 REST OF EUROPE Table 52: Rest of Europe Isostearic Acid Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 Table 53: Isostearic Acid Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019 Table 54: Rest of Europe Isostearic Acid Market Share Analysis by Application: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 55: Asia-Pacific Isostearic Acid Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 56: Isostearic Acid Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019 Table 57: Asia-Pacific Isostearic Acid Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 58: Isostearic Acid Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027 Table 59: Asia-Pacific Isostearic Acid Historic Market Review in US$ Thousand by Application: 2012-2019 Table 60: Asia-Pacific Isostearic Acid Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 AUSTRALIA Table 61: Isostearic Acid Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 Table 62: Australian Isostearic Acid Market in Retrospect in US$ Thousand by Application: 2012-2019 Table 63: Isostearic Acid Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027 INDIA Table 64: Indian Isostearic Acid Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 Table 65: Isostearic Acid Market in India: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019 Table 66: Indian Isostearic Acid Market Share Analysis by Application: 2012 VS 2020 VS 2027 SOUTH KOREA Table 67: Isostearic Acid Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2020-2027 Table 68: South Korean Isostearic Acid Historic Market Analysis in US$ Thousand by Application: 2012-2019 Table 69: Isostearic Acid Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 70: Rest of Asia-Pacific Demand Estimates and Forecasts for Isostearic Acid in US$ Thousand by Application: 2020 to 2027 Table 71: Rest of Asia-Pacific Isostearic Acid Market in US$ Thousand by Application: 2012-2019 Table 72: Isostearic Acid Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027 LATIN AMERICA Table 73: Latin American Isostearic Acid Market Trends by Region/Country in US$ Thousand: 2020-2027 Table 74: Isostearic Acid Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019 Table 75: Latin American Isostearic Acid Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 76: Latin American Demand for Isostearic Acid in US$ Thousand by Application: 2020 to 2027 Table 77: Isostearic Acid Market Review in Latin America in US$ Thousand by Application: 2012-2019 Table 78: Latin American Isostearic Acid Market Share Breakdown by Application: 2012 VS 2020 VS 2027 ARGENTINA Table 79: Argentinean Isostearic Acid Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 Table 80: Isostearic Acid Market in Argentina: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019 Table 81: Argentinean Isostearic Acid Market Share Analysis by Application: 2012 VS 2020 VS 2027 BRAZIL Table 82: Isostearic Acid Quantitative Demand Analysis in Brazil in US$ Thousand by Application: 2020-2027 Table 83: Brazilian Isostearic Acid Historic Market Review in US$ Thousand by Application: 2012-2019 Table 84: Brazilian Isostearic Acid Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 MEXICO Table 85: Isostearic Acid Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 Table 86: Mexican Isostearic Acid Market in Retrospect in US$ Thousand by Application: 2012-2019 Table 87: Isostearic Acid Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 88: Rest of Latin America Isostearic Acid Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 Table 89: Isostearic Acid Historic Demand Patterns in Rest of Latin America by Application in US$ Thousand for 2012-2019 Table 90: Isostearic Acid Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027 MIDDLE EAST Table 91: The Middle East Isostearic Acid Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 92: Isostearic Acid Market in the Middle East by Region/Country in US$ Thousand: 2012-2019 Table 93: The Middle East Isostearic Acid Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Table 94: The Middle East Isostearic Acid Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 Table 95: Isostearic Acid Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019 Table 96: The Middle East Isostearic Acid Market Share Analysis by Application: 2012 VS 2020 VS 2027 IRAN Table 97: Iranian Demand Estimates and Forecasts for Isostearic Acid in US$ Thousand by Application: 2020 to 2027 Table 98: Iranian Isostearic Acid Market in US$ Thousand by Application: 2012-2019 Table 99: Isostearic Acid Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027 ISRAEL Table 100: Israeli Isostearic Acid Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 Table 101: Isostearic Acid Market in Israel: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019 Table 102: Israeli Isostearic Acid Market Share Analysis by Application: 2012 VS 2020 VS 2027 SAUDI ARABIA Table 103: Saudi Arabian Demand for Isostearic Acid in US$ Thousand by Application: 2020 to 2027 Table 104: Isostearic Acid Market Review in Saudi Arabia in US$ Thousand by Application: 2012-2019 Table 105: Saudi Arabian Isostearic Acid Market Share Breakdown by Application: 2012 VS 2020 VS 2027 UNITED ARAB EMIRATES Table 106: Isostearic Acid Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2020-2027 Table 107: United Arab Emirates Isostearic Acid Historic Market Analysis in US$ Thousand by Application: 2012-2019 Table 108: Isostearic Acid Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027 REST OF MIDDLE EAST Table 109: Isostearic Acid Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 Table 110: Rest of Middle East Isostearic Acid Market in Retrospect in US$ Thousand by Application: 2012-2019 Table 111: Isostearic Acid Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027 AFRICA Table 112: African Isostearic Acid Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 Table 113: Isostearic Acid Historic Demand Patterns in Africa by Application in US$ Thousand for 2012-2019 Table 114: Isostearic Acid Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027 IV. COMPETITION Total Companies Profiled: 38 Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

100 项与 Vantage Specialty Ingredients, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Vantage Specialty Ingredients, Inc. 相关的转化医学

登录后查看更多信息